Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Winton

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Oncogene|February 14, 2007
Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient miceF Luo, D G Brooks, H Ye, et al.
Cancer Research|April 1, 1994
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestineR A Brooks, N J Gooderham, K Zhao, et al.
Mutation Research|August 26, 1998
Gene-mutation assays in lambda lacZ transgenic mice: comparison of lacZ with endogenous genes in splenocytes and small intestinal epitheliumJ H van Delft, A Bergmans, F J van Dam, et al.
Carcinogenesis|April 7, 2000
In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazineN J Toft, O J Sansom, R A Brookes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestineN J Toft, D J Winton, J Kelly, et al.
Oncogene|September 7, 2010
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formationI Ahmad, J P Morton, L B Singh, et al.
Nature Communications|March 21, 2018
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cellsD J Huels, L Bruens, M C Hodder, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Oncogene|February 14, 2007
Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient miceF Luo, D G Brooks, H Ye, et al.
Cancer Research|April 1, 1994
2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestineR A Brooks, N J Gooderham, K Zhao, et al.
Mutation Research|August 26, 1998
Gene-mutation assays in lambda lacZ transgenic mice: comparison of lacZ with endogenous genes in splenocytes and small intestinal epitheliumJ H van Delft, A Bergmans, F J van Dam, et al.
Carcinogenesis|April 7, 2000
In vivo administration of O(6)-benzylguanine does not influence apoptosis or mutation frequency following DNA damage in the murine intestine, but does inhibit P450-dependent activation of dacarbazineN J Toft, O J Sansom, R A Brookes, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 31, 1999
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestineN J Toft, D J Winton, J Kelly, et al.
Oncogene|September 7, 2010
β-Catenin activation synergizes with PTEN loss to cause bladder cancer formationI Ahmad, J P Morton, L B Singh, et al.
Nature Communications|March 21, 2018
Wnt ligands influence tumour initiation by controlling the number of intestinal stem cellsD J Huels, L Bruens, M C Hodder, et al.
Pageof 3